Anti-Porphyromonas gingivalis lipopolysaccharide antibody in rheumatoid arthritis patients …
Front. Med. Sec. Rheumatology. Volume 12 – 2025 | doi: 10.3389/fmed.2025.1654271 …
Google News
RheumNow
SMART study from India finally published. RCT compare split-dose to single-dose oral MTX, in 253 RA pts. Split dose was
SMART study from India finally published. RCT compare split-dose to single-dose oral MTX, in 253 RA pts. Split dose was
Google News
First Year Is Worst for Clotting Events in Lupus Patients – MedPage Today
Rheumatology. Lupus, RA Hit Pregnant Veterans Hard. 2. Laughing women with tennis rackets on the court. Rheumatology. ‘Weekend Warriors’ See
First Year Is Worst for Clotting Events in Lupus Patients
(MedPage Today) — For patients with new-onset systemic lupus erythematosus (SLE) who also developed antiphospholipid syndrome (APS), most thromboembolic events
RheumNow
LTBI risk in rheumatic pts is high (22%). Metanalysis 18 studies, 12,167 rheum pts shows LTBI signif. incr w/ current sm
LTBI risk in rheumatic pts is high (22%). Metanalysis 18 studies, 12,167 rheum pts shows LTBI signif. incr w/ current
RheumNow
Retrospective French Health Data System Immune Checkpt inhibitor (ICI) study. Of 172,363 ICI-Rx adult pts, ICI myotoxici
Retrospective French Health Data System Immune Checkpt inhibitor (ICI) study. Of 172,363 ICI-Rx adult pts, ICI myotoxici https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
RheumNow
Connective tissue disease associated with interstitial lung disease (CTD-ILD) market is estimated to be $5.9 Billion USD
Connective tissue disease associated with interstitial lung disease (CTD-ILD) market is estimated to be $5.9 Billion USD https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
RheumNow
ILD Begins (8.29.2025) Dr. Jack Cush reviews the news and journal reports from https://t.co/V10S4oVFsv. This week news
ILD Begins (8.29.2025) Dr. Jack Cush reviews the news and journal reports from https://t.co/V10S4oVFsv. This week news https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
Google News
AI Tool Detects Lupus From Eye Scans | Conexiant
… rheumatology specialists in head-to-head comparisons, according to research published in Cell Reports Medicine. The AI system, called DeepSLE …
Google News
Nurse Practitioner, COM, Department of Internal Medicine, Rheumatology, Allergy & Immunology
Nurse Practitioner, COM, Department of Internal Medicine, Rheumatology, Allergy & Immunology job in Cincinnati, Ohio, United States with …
RheumNow
Combined Therapy in Rheumatoid Arthritis Interstitial Lung Disease RA-ILD is a major therapeutic evidence gap in treat
Combined Therapy in Rheumatoid Arthritis Interstitial Lung Disease RA-ILD is a major therapeutic evidence gap in treat https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Thu,
RheumNow
Methotrexate significantly lowers Systolic BP
Methotrexate significantly lowers Systolic BP jjcush@gmail.com Thu, 09/04/2025 – 10:00
RheumNow
Abatacept and Methotrexate may Lower Risk of Interstitial Lung Disease in RA
Abatacept and Methotrexate may Lower Risk of Interstitial Lung Disease in RA jjcush@gmail.com Thu, 09/04/2025 – 10:00
Helio.com
Q&A: Medical misinformation and disinformation ‘getting worse’
Medical misinformation and disinformation are running rampant, taking up more time in already jam-packed primary care visits and impacting physicians’
Science Direct
Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial
Publication date: Available online 3 September 2025 Source: The Lancet Rheumatology Author(s): Gabriele De Marco, Elizabeth M A Hensor, Philip
Science Direct
Challenges in the therapeutic management of psoriatic arthritis
Publication date: Available online 3 September 2025 Source: The Lancet Rheumatology Author(s): Dafna D Gladman
PubMed
The NEON (Nerve rEpair Or Not) trial: a randomized controlled trial of microsurgical repair versus nerve alignment for digital nerve injury
Br J Surg. 2025 Sep 2;112(9):znaf174. doi: 10.1093/bjs/znaf174. ABSTRACT BACKGROUND: Digital nerves provide sensibility to the fingers. They are commonly
PubMed
Clinical characteristics of 24 cases of immune checkpoint inhibitors-induced type 1 diabetes
Zhonghua Nei Ke Za Zhi. 2025 Sep 1;64(9):831-837. doi: 10.3760/cma.j.cn112138-20250508-00262. ABSTRACT Objective: To analyze the clinical characteristics of immune checkpoint
PubMed
Gut microbiota and ankylosing spondylitis: current insights and future challenges
Microb Cell. 2025 Aug 25;12:210-230. doi: 10.15698/mic2025.08.857. eCollection 2025. ABSTRACT Ankylosing spondylitis (AS) is a chronic inflammatory disease with complex
PubMed
Association between impaired lung function and risk of spondyloarthritis: a cross-sectional study in the UK Biobank
Ther Adv Musculoskelet Dis. 2025 Sep 1;17:1759720X251371112. doi: 10.1177/1759720X251371112. eCollection 2025. ABSTRACT BACKGROUND: Impaired lung function has been noted in
PubMed
From diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome
Rheumatol Int. 2025 Sep 4;45(9):217. doi: 10.1007/s00296-025-05963-8. ABSTRACT BACKGROUND: VEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a recently
PubMed
Association of bushfire-associated air pollution and giant cell arteritis in the Australian Capital Territory and surrounding regional New South Wales
Intern Med J. 2025 Sep 4. doi: 10.1111/imj.70195. Online ahead of print. ABSTRACT BACKGROUND: Giant cell arteritis (GCA) has possible
PubMed
Multi-Omics Integration with Machine Learning and Molecular Docking Reveals Crosstalk Mechanisms and Drug Candidates in Metastatic Melanoma and Vitiligo
Clin Cosmet Investig Dermatol. 2025 Aug 29;18:2047-2066. doi: 10.2147/CCID.S533281. eCollection 2025. ABSTRACT OBJECTIVE: The aim of this study was to
PubMed
Progress in targeted therapies for type Ⅰ interferon pathway in systemic lupus erythematosus
Zhonghua Nei Ke Za Zhi. 2025 Sep 1;64(9):891-899. doi: 10.3760/cma.j.cn112138-20240927-00610. ABSTRACT 系统性红斑狼疮（SLE）的发病机制复杂，目前治疗选择相对有限。Ⅰ型干扰素通路作为同时调控固有与适应性免疫的核心致病机制，已成为药物研发关键靶点。靶向Ⅰ型干扰素受体的anifrolumab 是近十年首个获批治疗中重度SLE的创新生物制剂。围绕Ⅰ型干扰素的产生和受体激活通路的多种靶向治疗药物正处于不同研发阶段。各靶向药物在临床应用中表现出不同的疗效和特点，差异可能源于作用机制特异性及患者异质性。本综述系统阐述Ⅰ型干扰素通路致病机制与靶向治疗策略的前沿进展，旨在为临床精准用药提供理论依据。. PMID:40904301 | DOI:10.3760/cma.j.cn112138-20240927-00610
PubMed
Modulatory effects of transcranial direct current stimulation on sensory gating in Fibromyalgia Syndrome
Front Psychol. 2025 Aug 19;16:1607317. doi: 10.3389/fpsyg.2025.1607317. eCollection 2025. ABSTRACT INTRODUCTION: Several studies have demonstrated a reduced habituation to redundant
PubMed
The Causal Mechanism Between the Dipeptidyl Peptidase-4, Heart Failure, and Other Cardiovascular Diseases: A Mendelian Randomization and Mediation Study
Int J Endocrinol. 2025 Aug 26;2025:2357272. doi: 10.1155/ije/2357272. eCollection 2025. ABSTRACT Aims: Dipeptidyl peptidase-4 (DPP4) inhibitors are commonly used to
PubMed
A Clinical Case of Methotrexate Toxicity
J Med Cases. 2025 Aug 22;16(8):314-317. doi: 10.14740/jmc5159. eCollection 2025 Aug. ABSTRACT Methotrexate is a commonly prescribed immunosuppressant and chemotherapy